Carbon dioxide (CO2) insufflation is increasingly being used in gastrointestinal endoscopy as a method to enhance patient comfort and improve procedural outcomes. Traditionally, air was used for ...

The intelligent insufflation system adjusts the insufflation pressure to the prevailing intraabdominal status thus providing highest safety for the patient.

Stifel analysts maintained their Buy rating and $72.00 price target for CONMED Corporation (NYSE:CNMD), a medical technology company. According to InvestingPro analysis, CNMD appears undervalued, with ...